Effects of Risperidone and Galantamine Treatment on Alzheimer’s Disease Biomarker Levels in Cerebrospinal Fluid-Reference-Cited by-同舟云学术

Effects of Risperidone and Galantamine Treatment on Alzheimer’s Disease Biomarker Levels in Cerebrospinal Fluid

Published:2017-03-21 Issue:2 Volume:57 Page:387-393
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Bloniecki Victor¹,Aarsland Dag¹²³,Blennow Kaj⁴⁵,Cummings Jeffrey⁶,Falahati Farshad¹,Winblad Bengt⁷,Freund-Levi Yvonne¹²

Affiliation:

1. Department of Neurobiology, Caring Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institute, Stockholm, Sweden

2. Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden

3. Center for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway

4. Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Gothenburg, Sweden

5. Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden

6. Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA

7. Department of Neurobiology, Karolinska Institute, Caring Sciences and Society (NVS), Center for Alzheimer Research, Division of Neurogeriatrics, Huddinge, Sweden

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference32 articles.

1. Neuropsychiatric symptoms in Alzheimer’sdisease;Lyketsos;Alzheimers Dement,2011

2. Neuropsychiatric symptoms as the main determinant of caregiver burden in Alzheimer’s disease;Cerveira;Alzheimers Dement,2011

3. Clinicopathological correlates of behavioral and psychological symptoms of dementia;Casanova;Acta Neuropathol,2011

4. Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer’s disease;Vermeiren;J Alzheimers Dis,2014

5. Behavioral and psychological symptoms of dementia;Cerejeira;Front Neurol,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower Cerebrospinal Fluid Amyloid-β42 Predicts Sooner Time to Antipsychotic Use in Alzheimer’s Disease;Journal of Alzheimer's Disease Reports;2023-06-19

2. The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer’s Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials;Current Neuropharmacology;2022-10

3. The Viability of Treatment Conditioned to the Pathophysiology of Alzheimer’s Disease;Pharmacological Treatment of Alzheimer's Disease;2022

4. Fitoquímica, actividad biológica y farmacológica de plantas medicinales del sur de Ecuador;Productos naturales: investigación y perspectivas en Ecuador;2022

5. The Development of Pharmacological Therapies for Alzheimer’s Disease;Neurology and Therapy;2021-09-16